TRX.L

Tissue Regenix Group plc TRX.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TRX.L CIZ.L FUM.L NFX.L CNSL.L OPTI.L TCF.L CRTX.L RUA.L PRM.L
6M -75.34 % 0.00 % -80.76 % 140.00 % 5.56 % -49.14 % -6.67 % 15.79 % 2.22 % -33.74 %
YTD -84.62 % -3.13 % -94.10 % 500.00 % 1.79 % -51.89 % -60.00 % 4.76 % 6.98 % -43.68 %
1Y -83.33 % -20.51 % -94.20 % 400.00 % -18.57 % -39.66 % -71.03 % 15.79 % -22.03 % -36.17 %
3Y -82.00 % -1.59 % -95.39 % -15.49 % 11.76 % -46.87 % -95.53 % -95.74 % -69.74 % -57.44 %
5Y -75.00 % -83.47 % -86.98 % -90.48 % -96.97 % -83.96 % -98.32 % -97.27 % -91.59 % -52.72 %
10Y -99.44 % -83.47 % -92.82 % -88.57 % -79.20 % -82.97 % -99.39 % -99.99 % -69.17 % -89.36 %
From the beginning -99.60 % -83.47 % -97.39 % -88.57 % -99.99 % -99.75 % -99.39 % -100.00 % -99.16 % -98.75 %

Dividend

CRISM Therapeutics Corporation